Table 1.
Variables | Training set | Validation set | P | ||
---|---|---|---|---|---|
N | % | N | % | ||
Age | 0.221 | ||||
<60 | 110 | 61.1 | 48 | 53.3 | |
≥60 | 70 | 38.9 | 42 | 46.7 | |
Sex | 0.503 | ||||
Female | 53 | 29.4 | 23 | 25.6 | |
Male | 127 | 70.6 | 67 | 74.4 | |
Grade | 0.438 | ||||
I-II | 89 | 49.4 | 49 | 54.4 | |
III-IV | 91 | 50.6 | 41 | 45.6 | |
Stage | 0.351 | ||||
I | 144 | 80 | 69 | 76.7 | |
II | 20 | 11.1 | 8 | 8.9 | |
III | 16 | 8.9 | 13 | 14.4 | |
Histological type | 0.438 | ||||
ccRCC | 149 | 82.8 | 71 | 78.9 | |
pRCC | 31 | 17.2 | 19 | 21.1 |
FUSCC: Fudan University Shanghai Cancer Center; ccRCC: clear cell renal cell cancer; pRCC: papillary renal cell cancer.